|
|||||
|
|
First-line endocrine therapy alone could be a reasonable treatment option for hormone-positive, HER2-positive metastatic breast cancer |
|
| Authors: | Peron Julien Tredan Olivier Ray-Coquard Isabelle Bachelot Thomas Labidi Galy Sana Intidhar Favier Bertrand Treilleux Isabelle Guastalla Jean-Paul |
| Affiliation: | Centre Léon-Bérard, Department of Medical Oncology, 28, rue Laennec, 69008 Lyon, France. julien.peron@ymail.com |
| Abstract: | |
| Keywords: | metastatic breast cancer ER-positive HER2-positive endocrine therapy trastuzumab |
| 本文献已被 ScienceDirect PubMed 等数据库收录！ | |